SecurityOGRMF / Organigram Holdings, Inc. (68620P101)
IndustryCannabis and Medical Marijuana Dispensaries
Institutional Owners5
Institutional Shares38,035
Institutional Value$ 200,000 USD

Institutional Stock Ownership and Shareholders

Organigram Holdings, Inc. (OTC:OGRMF) has 5 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 38,035 shares. Largest shareholders include Rothschild Investment Corp /il, Intercontinental Wealth Advisors, Llc, AlphaMark Advisors, LLC, Horrell Capital Management, Inc., and CENTRAL TRUST Co.
Organigram Holdings, Inc. (OTC:OGRMF) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-10-04 13F-HR Horrell Capital Management, Inc. 1,000 5
2018-10-17 13F-HR ROTHSCHILD INVESTMENT CORP /IL 24,100 129
2018-10-16 13F-HR Intercontinental Wealth Advisors, Llc 11,366 60
2018-08-03 13F-HR AlphaMark Advisors, LLC 1,469 6
2018-10-04 13F-HR CENTRAL TRUST Co 100 0
OGRMF: Organigram Holdings (TSXV:OGI) Analysis and Research Report

2017-12-18 - Asif

Organigram Holdings is licensed as a Licensed Producer of medical marijuana, including dried cannabis and cannabis oil, under the ACMPR. Pursuant to its license, the Company is permitted to possess, produce, sell, provide, ship, deliver, transport and destroy medical marijuana, marijuana plants (including plants and seeds) and cannabis oil, in conformity with the ACMPR, and made its first shipment of medical marijuana to registered patients in September 2014. As at the date hereof, the Company has one of 32 licenses to produce and sell medical marijuana and one of 20 licenses to produce and sell cannabis oil under the ACMPR. The Company has the only license to produce and sell both medical marijuana and cannabis oil in Atlantic Canada. Moreover, management believes that the Company benefits from a number of competitive advantages which will allow it to be strategically positioned for future potential developments in the industry. The Company has entered into agreements with sever...

Related News Stories

As cannabis D-Day approaches, winners and losers set to emerge

2018-10-15 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com (9-2)

The No.1 Story In Cannabis Markets Today

2018-10-02 oilprice
Your license and viewing of our content is subject to the disclosures contained after this article. (5-4)

Top Marijuana Stocks Offering New Opportunities For Investors

2018-10-02 seekingalpha
Canada is set to flip the switch for legal sale of recreational marijuana in just a few weeks. (13-2)

Fund manager sees potential in pot stocks — but also ‘scary down days’

2018-09-13 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com (8-1)

Tilray In 2 Words; Sell It. It Is Trading At 156x Forward Sales

2018-08-29 seekingalpha
The company focuses on the production of medical cannabis in Canada and Europe, and the supply of high-quality cannabis products. (10-1)

CUSIP: 68620P101